Amazing news from ESMO
Amazing news from ESMO – European Society for Medical Oncology‘s congress – these early Phase 1 Trial results suggest genetically engineered cancer-killing viruses could potentially offer hope to some patients where other forms of immunotherapy have not worked. Great job, The Institute of Cancer Research! The engineered herpes RP2 virus injected directly into the tumours, […]
EMA recommendation on biosimilars
This is the first time that the European Medicines Agency has made a recommendation on biosimilars. What is it going to change? While the statement has no immediate legal implications, it is predicted to strengthen the position of biosimilars in the EU. Read more: EMA and HMA support interchangeability of biosimilars – decision regarding substitution […]
A big day for biosimilars!
The EMA issued a statement confirming that all biosimilars approved in the EU are interchangeable with other approved biosimilars referencing the same biologic, as well as the reference biologic itself. 86 biosimilars have been approved in the EU so far. EMA news, 19.09.2023
Arthritis biosimilar study – recent large earlyphase project
One of our recent large earlyphase projects was a study on a biosimilar for the management of arthritis. We’ve been observing a growing interest from sponsors in this area. Biosimilars are already widely used and accepted in Europe, and will eventually start penetrating the market due to growing availability to real-world data on long term safety […]
Dual Enrollment
Safety and Health of study volunteers is always of utmost importance to us.
We hiring Quality Control Specialist
Do you want to join our growing team or know someone who could be a good fit? We are currently looking for a Quality Control Specialist to join Biokinetica. Join our team on LinkedIn jobs or find Job offer at our career page (in polish).
PCMG ANNUAL ASSEMBLY 2022 in Cracow
The Pharmaceutical Contract Management Group Conference in Cracow has kicked off. Let’s talk about harnessing pandemic changes and practices. Will the efficiencies implemented during COVID stay with us for good? What are the solutions for high sponsor expectations when cost pressures mix with clinical trials skills shortage? We will look for answers at PCGM in Krakow. Event website LinkedIn […]
Face-to-face in Barcelona – ERS Congress
The European Respiratory Society International Congress has started today in #Barcelona. Our team is here and ready to connect – we are looking forward to meeting you face-to-face again! The #ERSCongress is a once-a-year occasion when the world’s #respiratory experts come together to present and discuss the latest scientific and clinical advances across the field of respiratory medicine. The topics […]
Clinical trial integrity during outbreak
In her session of our latest seminar Wendy van Faassen adressed how ICON plc coped with multisite trial management sites during COVID-19, and what strategies were implemented to ensure clinical trial integrity. If you missed this presentation, you can watch it on YouTube.
Did you miss our last webinar?
You can access all the sessions on YouTube. Each one is a fantastic source of experts’ learnings from early phase clinical trials during the pandemic that you can implement in your drug development process.
